Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Avadel Pharmaceuticals plc is not a good value stock. Avadel Pharmaceuticals plc is not a good growth stock. Avadel Pharmaceuticals plc is a mediocre stock to choose.
Log in to see more information.
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical produc...

News

Health Check: How Prudently Does Avadel Pharmaceuticals (NASDAQ:AVDL) Use Debt?
Health Check: How Prudently Does Avadel Pharmaceuticals (NASDAQ:AVDL) Use Debt?

Simply Wall St Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...\n more…

Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Rating Reaffirmed by Needham & Company LLC
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Rating Reaffirmed by Needham & Company LLC

Ticker Report Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report)s stock had its "buy" rating reissued by equities research analysts at Needham Company LLC in a report issued on Wednesday...\n more…

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ  Dosing (sodium oxybate)
Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ Dosing (sodium oxybate)

Globe Newswire Survey data demonstrate 94% of people with narcolepsy prefer the once-nightly regimen of LUMRYZ over twice-nightly oxybate regimens 91% reported being better able to sleep through the night...\n more…

Avadel Pharmaceuticals (NASDAQ:AVDL) Rating Reiterated by HC Wainwright
Avadel Pharmaceuticals (NASDAQ:AVDL) Rating Reiterated by HC Wainwright

Ticker Report Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report)s stock had its "buy" rating reiterated by research analysts at HC Wainwright in a research report issued to clients and investors on...\n more…

Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC Wainwright
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC Wainwright

Zolmax Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report)s stock had its "buy" rating restated by stock analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They...\n more…

AVDL Crosses Below Key Moving Average Level
AVDL Crosses Below Key Moving Average Level

Market News Video In trading on Wednesday, shares of Avadel Pharmaceuticals PLC (AVDL) crossed below their 200 day moving average of 15.19, changing hands as low as 14.11 per share. Avadel Pharmaceuticals...\n more…